Trends of Medication Usage and Associated Outcomes for Taiwanese Patients with Inflammatory Bowel Disease from 2001 to 2015
出版年份 2018 全文链接
标题
Trends of Medication Usage and Associated Outcomes for Taiwanese Patients with Inflammatory Bowel Disease from 2001 to 2015
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 7, Issue 11, Pages 394
出版商
MDPI AG
发表日期
2018-10-29
DOI
10.3390/jcm7110394
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor–Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease
- (2018) Wan-Ju Lee et al. INFLAMMATORY BOWEL DISEASES
- Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions
- (2018) Gregory S. Calip et al. INTERNATIONAL JOURNAL OF CANCER
- Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
- (2018) Hau-Jyun Su et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study
- (2017) Christopher Alexakis et al. INFLAMMATORY BOWEL DISEASES
- Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease
- (2017) Magali Lemaitre et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
- (2017) Marcus Harbord et al. Journal of Crohns & Colitis
- Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials
- (2017) Zheng Zhang et al. BMJ Open
- Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea
- (2016) S. N. Hong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis
- (2016) E. J. Mao et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
- (2016) Fernando Gomollón et al. Journal of Crohns & Colitis
- Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use
- (2016) E. Guirao-Arrabal et al. Transplant Infectious Disease
- PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation
- (2015) Kyle Dammann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Infection risk associated with anti-TNF-α agents: a review
- (2015) Giuseppe Murdaca et al. Expert Opinion On Drug Safety
- Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
- (2015) Aparna Schweitzer et al. LANCET
- Biologic agents for IBD: practical insights
- (2015) Silvio Danese et al. Nature Reviews Gastroenterology & Hepatology
- Immunopathogenesis of IBD: current state of the art
- (2015) Heitor S. P. de Souza et al. Nature Reviews Gastroenterology & Hepatology
- Peroxisome Proliferator-Activated Receptors Family Is Involved in the Response to Treatment and Mild Clinical Course in Patients with Ulcerative Colitis
- (2014) J. K. Yamamoto-Furusho et al. DISEASE MARKERS
- The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
- (2014) Aleksandar D. Kostic et al. GASTROENTEROLOGY
- The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ
- (2013) Christel Rousseaux et al. CARCINOGENESIS
- Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)
- (2013) Fernando Magro et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations
- (2012) Gert Van Assche et al. Journal of Crohns & Colitis
- Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: A review
- (2012) Kavitha Subramaniam et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Long-term follow-up of ulcerative colitis in Taiwan
- (2012) Shu-Chen Wei et al. Journal of the Chinese Medical Association
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Safety
- (2011) Gert Van Assche et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases
- (2011) Benoit Chassaing et al. GASTROENTEROLOGY
- Genetics and pathogenesis of inflammatory bowel disease
- (2011) Bernard Khor et al. NATURE
- Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy
- (2011) María Luisa Manzano-Alonso WORLD JOURNAL OF GASTROENTEROLOGY
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
- (2010) A. Dignass et al. Journal of Crohns & Colitis
- A Comprehensive Review of the Adverse Effects of Systemic Corticosteroids
- (2010) David M. Poetker et al. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA
- Long-term Follow-up of Ulcerative Colitis in the Chinese Population
- (2009) Dorothy K L Chow et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Prevalence of ulcerative colitis and Crohn’s disease in Japan
- (2009) Keiko Asakura et al. JOURNAL OF GASTROENTEROLOGY
- An Update on the Epidemiology of Inflammatory Bowel Disease in Asia
- (2008) Kelvin T. Thia et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: A KASID study
- (2007) Suk-Kyun Yang et al. INFLAMMATORY BOWEL DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started